ImmunityBio Ownership | Who Owns ImmunityBio?


OverviewForecastRevenueFinancialsChart

ImmunityBio Ownership Summary


ImmunityBio is owned by 9.86% institutional investors, 77.00% insiders, and 13.14% retail investors. Vanguard group is the largest institutional shareholder, holding 2.06% of IBRX shares. Vanguard Total Stock Mkt Idx Inv is the top mutual fund, with 0.82% of its assets in ImmunityBio shares.

IBRX Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockImmunityBio9.86%77.00%13.14%
SectorHealthcare Stocks 49.73%8.84%41.43%
IndustryBiotech Stocks 47.04%8.74%44.21%

Institutional Shareholders


Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Vanguard group13.83M2.06%$87.42M
Blackrock11.42M1.70%$72.19M
State street7.86M1.17%$49.70M
Geode capital management3.92M0.58%$24.76M
Jane street group1.72M0.26%$10.85M
Ubs asset management americas1.58M0.23%$9.97M
Cormorant asset management, lp1.25M0.19%$7.90M
Charles schwab investment management1.24M0.18%$7.81M
Jpmorgan chase1.18M0.18%$7.48M
Northern trust1.14M0.17%$7.22M

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Harbourvest partners335.71K1.13%$2.12M
Accurate wealth management560.00K0.85%$3.56M
Allen inc /ny687.57K0.54%$4.35M
Sheets smith wealth management666.00K0.50%$4.21M
Cormorant asset management, lp1.25M0.46%$7.90M
Clearwater capital advisors482.55K0.32%$3.05M
Wealth effects87.50K0.20%$553.00K
Meridian investment counsel96.43K0.19%$609.46K
Virtus etf advisers56.11K0.17%$354.60K
Collective family office70.36K0.13%$444.64K

Top Buyers

HolderShares% AssetsChange
Jane street group1.72M0.00%1.41M
Ubs asset management americas1.58M0.00%1.39M
Cormorant asset management, lp1.25M0.46%1.25M
Blackrock11.42M0.00%1.05M
First trust advisors lp887.62K0.01%887.62K

Top Sellers

HolderShares% AssetsChange
State street7.86M0.00%-6.32M
Invesco61.02K0.00%-1.21M
Perceptive advisors---1.05M
Citigroup108.99K0.00%-1.02M
Rafferty asset management435.65K0.01%-874.74K

New Positions

HolderShares% AssetsChangeValue
Cormorant asset management, lp1.25M0.46%1.25M$7.90M
First trust advisors lp887.62K0.01%887.62K$5.61M
Accurate wealth management560.00K0.85%560.00K$3.56M
Woodline partners lp437.84K0.03%437.84K$2.77M
Balyasny asset management207.20K0.00%207.20K$1.31M

Sold Out

HolderChange
Investors research-15.00
Financial gravity asset management-17.00
Nelson, van denburg & campbell wealth management group-26.00
Central bank & trust-80.00
Thurston, springer, miller, herd & titak-100.00

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Sep 30, 2024189-8.25%68,622,14511.64%912.32%85-23.42%41-12.77%
Jun 30, 202420412.09%61,450,416-7.05%95.41%11023.60%4711.90%
Mar 31, 202418221.33%66,112,58815.46%129.85%899.88%4240.00%
Dec 31, 20231509.49%57,262,19215.61%118.96%8130.65%30-3.23%
Sep 30, 20231378.73%49,528,61126.96%1113.65%62-8.82%3140.91%

Top Mutual Funds Shareholders


HolderShares% HoldingChange
Vanguard Total Stock Mkt Idx Inv5.73M0.82%8.20K
SPDR® S&P Biotech ETF5.03M0.72%55.60K
Vanguard Small Cap Index4.37M0.63%8.55K
iShares Russell 2000 ETF3.74M0.54%-8.41K
Vanguard Small Cap Growth Index Inv2.41M0.35%1.34K
Vanguard Institutional Extnd Mkt Idx Tr2.40M0.34%-44.76K
Fidelity Small Cap Index1.45M0.21%-36.08K
iShares Russell 2000 Growth ETF1.02M0.15%-
State St Russell Sm/Mid Cp® Indx NL Cl C947.17K0.14%-31.80K
Fidelity Extended Market Index932.42K0.13%-21.16K

Recent Insider Transactions


DateNameRoleActivityValue
Sep 11, 2023SOON-SHIONG PATRICK See remarksBuy-
Jun 05, 2023BLASZYK MICHAEL D-Buy$132.96K
Jun 05, 2023BLASZYK MICHAEL D-Buy$1.33K
Jun 05, 2023BLASZYK MICHAEL D-Buy$63.73K
Jun 02, 2023Brennan John Owen-Buy$29.00K

Insider Transactions Trends


DateBuySell
2024 Q4--
2024 Q2--
2024 Q1--
2023 Q4--
2023 Q31-

IBRX Ownership FAQ


Who Owns ImmunityBio?

ImmunityBio shareholders are primarily institutional investors at 9.86%, followed by 77.00% insiders and 13.14% retail investors. The average institutional ownership in ImmunityBio's industry, Biotech Stocks , is 47.04%, which ImmunityBio falls below.

Who owns the most shares of ImmunityBio?

ImmunityBio’s largest shareholders are Vanguard group (13.83M shares, 2.06%), Blackrock (11.42M shares, 1.70%), and State street (7.86M shares, 1.17%). Together, they hold 4.92% of ImmunityBio’s total shares outstanding.

Does Blackrock own ImmunityBio?

Yes, BlackRock owns 1.70% of ImmunityBio, totaling 11.42M shares as of Jun 2024. This represents 0.00% of BlackRock's total assets, with a market value of 72.19M$. In the last quarter, BlackRock increased its holdings by 1.05M shares, a 10.10% change.

Who is ImmunityBio’s biggest shareholder by percentage of total assets invested?

Harbourvest partners is ImmunityBio’s biggest shareholder by percentage of total assets invested, with 1.13% of its assets in 335.71K ImmunityBio shares, valued at 2.12M$.

Who is the top mutual fund holder of ImmunityBio shares?

Vanguard Total Stock Mkt Idx Inv is the top mutual fund holder of ImmunityBio shares, with 0.82% of its total shares outstanding invested in 5.73M ImmunityBio shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools